Sygnature Discovery
Biotechnology Research • 
Nottingham, England, United Kingdom • 501-1000 Employees
Company overview
| Headquarters | BioCity, Pennyfoot Street, Nottingham, NG1 1GR, GB |
| Phone number | +441159415401 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Drug Formulation, Protein Crystallography, Computational Chemistry & Informatics, Dmpk & Physical Sciences, In Vitro Bioscience, In Vivo Bioscience |
| Founded | 2004 |
| Employees | 501-1000 |
| Socials |
Key Contacts at Sygnature Discovery
Allan Jordan
Director Of Oncology Drug Discovery
Pascal Turcotte
Director Separation Sciences
Rachel Hemsley
Business Development Director
Ridwan Islam
Director, Business Development
Andrew Novak
Associate Director Of Drug Discovery Partnerships
Stuart Best
Deputy Director, Dmpk And Physical Sciences
Daniel Hamza
Associate Director
James Morey
Business Services Director
Jane Kendrew
Director Of Translational Oncology
Ross Jameson
Director Of Financial Planning And Development
Sygnature Discovery Email Formats
Sygnature Discovery uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@sygnaturediscovery.com), used 79.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@sygnaturediscovery.com | 79.9% |
{first initial}.{last name} | j.doe@sygnaturediscovery.com | 18.7% |
About Sygnature Discovery
Sygnature Discovery is a world-leading integrated drug discovery contract research organization based in the UK and Canada with headquarters in Nottingham (UK). Additional sites are located in Alderley Park, Macclesfield, and Glasgow (UK), as well as Montreal and Quebec City (Canada). Its team of over 1,000 employees, which includes 900 scientists, partners with global biotech, pharma and NFP organizations. Since 2011, Sygnature Discovery has delivered 50 novel pre-clinical and 30 clinical compounds, with its scientists named on over 170 patents. Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases, and more. Founded in 2004, we have delivered over 40 pre-clinical compounds, 21 clinical compounds, and our scientists are named on over 170 patent applications. We partner with global pharma, biotech, and NFP organizations, providing integrated drug discovery services from target identification through to candidate nomination. Our co-located teams are experts in protein science, chemistry, computational chemistry, in vitro biology, pharmacology, DMPK, form and formulation services, and project management, with a core therapeutic focus on oncology, inflammation and immunology, as well as neuroscience, metabolic diseases, respiratory, infectious diseases and fibrotic diseases.
Sygnature Discovery revenue & valuation
| Annual revenue | $68,500,000 |
| Revenue per employee | $103,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $219,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Sygnature Discovery has 109 employees across 13 departments.
Departments
Number of employees
Sygnature Discovery Tech Stack
Discover the technologies and tools that power Sygnature Discovery's digital infrastructure, from frameworks to analytics platforms.
Security
Digital asset management
Caching
Miscellaneous
CDN
SEO
Analytics
Miscellaneous
Programming languages
Blogs
Analytics
SEO
France
Germany
SlovakiaFrequently asked questions
4.8
40,000 users
